AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The Business Research Company's Sotrovimab Or Xevudy Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, February 7, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What's The Growth Projection For The Sotrovimab Or Xevudy Market?
Size projections indicate substantial growth in the sotrovimab or xevudy market, from $XX million in 2024 to a promising figure of $XX million in 2025, marking a compound annual growth rate CAGR of XX%. Drivers for this historic period growth include increased prevalence of COVID-19, surged demand for effective monoclonal antibody treatments, heightened awareness for high-risk patient care, increased government funding, and collaborations among pharmaceutical companies.
In the next few years, the sotrovimab or xevudy market is projected to grow further to $XX million in 2029, at a CAGR of XX%. Rising emergence of new COVID-19 variants, increasing focus on monoclonal antibody therapies, expanding healthcare access in developing countries, increased government support for pandemic preparedness, and growing telehealth services for treatment delivery are factors that will spur this growth.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20383&type=smp
What's Driving Growth In The Sotrovimab Or Xevudy Market?
Growth in the sotrovimab or xevudy market is majorly driven by the surge in prevalence of COVID-19 cases. COVID-19, spread by the SARS-CoV-2 virus through respiratory droplets, ranges from mild fever symptoms to severe respiratory issues. The increasing number of COVID-19 cases is attributed to factors such as new virus variants, lower immunity, eased restrictions, seasonal indoor gatherings, and uneven vaccine coverage. Sotrovimab or Xevudy aims to neutralize the virus early in high-risk COVID-19 patients, thus preventing severe outcomes like hospitalization or death. High prevalence of COVID-19 cases is thus expected to bode well for sotrovimab or xevudy market growth.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/sotrovimab-or-xevudy-global-market-report
Who Are The Key Market Players In The Sotrovimab Or Xevudy Market?
Major companies behind the thriving sotrovimab or xevudy market are GSK plc; Vir Biotechnology Inc. These key industry players continuously strive to improve their market positions by investing in research and development, strategic collaborations, and expanding production capacities to increase drug access.
What's The Latest Trend In The Sotrovimab Or Xevudy Market?
The latest development in the sotrovimab or xevudy market is the strategic partnerships to boost resources for research and development, expand production capacities, and improve drug accessibility. For instance, GSK plc, a UK-based pharmaceutical company, partnered with Vir Biotechnology Inc., in January 2022. With this partnership, they have announced a major agreement with the United States government to acquire additional supplies of sotrovimab, a monoclonal antibody authorized for the early treatment of COVID-19. This agreement aligns with the ongoing need for effective treatments as the pandemic continues to evolve, and reflects the broader strategy of GSK and Vir to ensure that sotrovimab stays accessible despite the emergence of new virus variants.
How Is The Sotrovimab Or Xevudy Market Segmented?
The sotrovimab or xevudy market has been segmented as follows:
1 By Indication: COVID-19 Early Treatment; Post-Exposure Prophylaxis
2 By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3 By End User: Pediatric; Adult; Geriatric.
What Does The Regional Spread Of The Sotrovimab Or Xevudy Market Look Like?
In 2024, North America was the dominant region in the sotrovimab or xevudy market. In the forecast period, Asia-Pacific is expected to be the fastest-growing region. The regions covered in the sotrovimab or xevudy market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse for more similar reports-
Virus Filtration Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/virus-filtration-global-market-report
Herpes Simplex Virus Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/herpes-simplex-virus-treatment-global-market-report
Antibody Drug Conjugates Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Get to know more about The Business Research Company. Leveraging more than 15000+ reports from 27 industries across 60+ geographies, The Business Research Company offers comprehensive, data-rich research and unique insights from industry leaders. With 1,500,000 datasets, detailed secondary research, and unique insights from industry leaders, we can keep you ahead in the game.
For more, contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Or via email at [email protected]
Stay ahead of the curve by following us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
